Cargando…

Risk of bleeding after hospitalization for a serious coronary event: a retrospective cohort study with nested case-control analyses

BACKGROUND: Bleeding events have been associated with the use of antiplatelet agents. This study estimated the incidence of bleeding events in patients previously hospitalized for a serious coronary event and determined the risks of bleeding associated with the use of acetylsalicylic acid (ASA) and/...

Descripción completa

Detalles Bibliográficos
Autores principales:	González-Pérez, Antonio, Sáez, María E., Johansson, Saga, Himmelmann, Anders, García Rodríguez, Luis A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006362/ https://www.ncbi.nlm.nih.gov/pubmed/27577589 http://dx.doi.org/10.1186/s12872-016-0348-6

Ejemplares similares

The association between serious upper gastrointestinal bleeding and incident bisphosphonate use: a population-based nested cohort study
por: Knopp-Sihota, Jennifer A, et al.
Publicado: (2013)

Development of hypotension in patients newly diagnosed with heart failure in UK general practice: retrospective cohort and nested case–control analyses
por: Martín-Pérez, Mar, et al.
Publicado: (2019)

Safety and effectiveness of appropriately and inappropriately dosed rivaroxaban or apixaban versus warfarin in patients with atrial fibrillation: a cohort study with nested case–control analyses from UK primary care
por: González-Pérez, Antonio, et al.
Publicado: (2022)

Incidence and predictors of serious bleeding during long-term follow-up after acute coronary syndrome in a population-based cohort study
por: Graipe, Anna, et al.
Publicado: (2021)

Risk of uncomplicated peptic ulcer disease in a cohort of new users of low-dose acetylsalicylic acid for secondary prevention of cardiovascular events
por: Ruigómez, Ana, et al.
Publicado: (2014)

Risk Factors Associated with Uncomplicated Peptic Ulcer and Changes in Medication Use after Diagnosis
por: González-Pérez, Antonio, et al.
Publicado: (2014)

Cardiovascular events and all-cause mortality in a cohort of 57,946 patients with type 2 diabetes: associations with renal function and cardiovascular risk factors
por: Cea Soriano, Lucia, et al.
Publicado: (2015)

Use of varenicline for smoking cessation and risk of serious cardiovascular events: nationwide cohort study
por: Svanström, Henrik, et al.
Publicado: (2012)

Young Asian men with diabetes have the highest risk for acute coronary events: retrospective cohort analyses
por: Basu, Ansu, et al.
Publicado: (2018)

Association between use of warfarin with common sulfonylureas and serious hypoglycemic events: retrospective cohort analysis
por: Romley, John A, et al.
Publicado: (2015)

Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding
por: Lindholm, Daniel, et al.
Publicado: (2017)

Impact of diabetes on bleeding events in ST-elevation myocardial infarction patients after urgent percutaneous coronary intervention: A retrospective cohort study
por: Zhang, Huairong, et al.
Publicado: (2016)

Procedure in the event of serious accidents
Publicado: (1974)

Low-dose aspirin and risk of upper/lower gastrointestinal bleeding by bleed severity: a cohort study with nested case-control analysis using primary care electronic health records from the United Kingdom
por: García Rodríguez, Luis A., et al.
Publicado: (2019)

Gastrointestinal Stromal Tumor: An Uncommon but Serious Cause of Gastrointestinal Bleeding
por: Alawawdeh, Firas, et al.
Publicado: (2021)

Serious bleeds in pediatric persons with hemophilia A on emicizumab prophylaxis
por: Garcia, Jessica, et al.
Publicado: (2023)

Prediction of gastrointestinal bleeding events in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational cohort study (STROBE compliant)
por: Zheng, Wen, et al.
Publicado: (2020)

Antiplatelet Therapy Discontinuation and the Risk of Serious Cardiovascular Events after Coronary Stenting: Observations from the CREDO-Kyoto Registry Cohort-2
por: Watanabe, Hirotoshi, et al.
Publicado: (2015)

Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
por: Bai, Zhichao, et al.
Publicado: (2023)

Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial
por: Ueland, Thor, et al.
Publicado: (2018)

Risk of mortality in a cohort of patients newly diagnosed with chronic atrial fibrillation
por: Ruigómez, Ana, et al.
Publicado: (2002)

Serious Neurological Adverse Events of Ceftriaxone
por: Lacroix, Clémence, et al.
Publicado: (2021)

Prevalence, predictors and outcomes of bleeding events in patients with COVID-19 infection on anticoagulation: Retrospective cohort study
por: Alkhamis, Ahmed, et al.
Publicado: (2021)

CRUSADE bleeding score as a predictor of bleeding events in patients with acute coronary syndrome in Zagazig University Hospital
por: Al-Daydamony, Mohamed M., et al.
Publicado: (2016)

Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk Scores
por: Natsuaki, Masahiro, et al.
Publicado: (2018)

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients: Nivolumab-related serious/fatal adverse events
por: Zhao, Bin, et al.
Publicado: (2018)

Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis
por: Ducrocq, Gregory, et al.
Publicado: (2010)

Serious Adverse Events Are Uncommon with Combination Neonatal Antiretroviral Prophylaxis: A Retrospective Case Review
por: Smith, Christiana, et al.
Publicado: (2015)

Identification of serious, unpredictable adverse events with tocilizumab
Publicado: (2020)

PB1924: INCIDENCE OF CARDIOVASCULAR AND BLEEDING EVENTS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS (CLL) TREATED WITH IBRUTINIB – A RETROSPECTIVE ANALYSIS ON CONSECUTIVE PATIENTS FROM A WELL-DEFINED REGION.
por: Andersson, Maria, et al.
Publicado: (2023)

Real‐world use of idarucizumab for dabigatran reversal in three cases of serious bleeding
por: Gendron, Nicolas, et al.
Publicado: (2017)

Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System
por: Duprey, Matthew S., et al.
Publicado: (2019)

The association between antihypertensive treatment and serious adverse events by age and frailty: A cohort study
por: Sheppard, James P., et al.
Publicado: (2023)

Association between liver fibrosis and thrombotic or bleeding events in acute coronary syndrome patients
por: Liu, Yupeng, et al.
Publicado: (2022)

Factors associated with bleeding events from enoxaparin used for patients with acute coronary syndrome
por: Weerasaksanti, Adisak, et al.
Publicado: (2023)

Factors associated with excessive bleeding in cardiopulmonary bypass patients: a nested case-control study
por: Jimenez Rivera, Juan J, et al.
Publicado: (2007)

Protocol for a Nested, Retrospective Study of the Australian Placental Transfusion Study Cohort
por: Tan-Koay, Ava G, et al.
Publicado: (2022)

Oral fluoroquinolone use and serious arrhythmia: bi-national cohort study
por: Inghammar, Malin, et al.
Publicado: (2016)

Invariant natural killer T cells and incidence of first-time coronary events: a nested case-control study
por: Tomas, Lukas, et al.
Publicado: (2023)

Amphetamines, Atomoxetine and the Risk of Serious Cardiovascular Events in Adults
por: Schelleman, Hedi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_kpajrfujj3f7bq6ma4rgjs6i0o